Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Complications of pregnancy have been found to be related with thrombophilic polymorphisms that explain about 30% of obstetric complications. We evaluated the angiotensin converting enzyme (ACE) and the angiotensin type 1 receptor (AT1R) gene polymorphisms in the renin-angiotensin system (RAS) as possible risk factors for fetal loss. Fifty-nine women with a history of three or more first-trimester fetal losses and 70 healthy women with a history of normal pregnancies were enrolled in this study. Thrombophilic factors, ACE insertion/deletion (I/D) and AT1R A1166C polymorphisms, prothrombin G20210A and factor V Leiden mutations were analyzed. At univariate and multivariate analysis, a significant association between ACE DD and AT1R CC genotype and fetal loss was observed. The effect of the ACE DD genotype on the risk of fetal loss was higher in AT1R C allele carriers. The prevalence of hyperhomocysteinemia (Hcy) (defined as baseline plasma levels higher than the 95% percentile; cut-off, 10.5 micromol/l per l) was significantly higher in women with fetal loss, and an association between Hcy and fetal loss was detected. All patients showed normal antithrombin, protein C, protein S, and plasminogen activator inhibitor-1 (PAI-1) values. The presence of one risk factor not associated with others was found in 33 out of 59 patients (56%); ACE DD genotype was the most prevalent risk factor. Our results identify new possible predictive markers for fetal loss in RAS polymorphisms and Hcy. Large-scale studies are warranted to attribute clinical relevance to these polymorphisms as risk factors for complicated pregnancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767 · cited 1×
“An insertion/deletion (I/D) polymorphism in the ACE gene has been associated with serum ACE activities: subjects with DD ACE genotype had higher levels than those with the ACE II genotype, and intermediate levels were observed in heterozygote ID [6].”
Background
Cited by
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Thrombophilia in pregnancy: a systematic review
Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G. D. O., Walker, I. D., Greaves, M., Brenkel, I., Regan, L., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05847.x · Cited by 849
Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Greaves, M., Walker, I., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489
Bradley, L. A., Palomaki, G. E., Bienstock, J., Varga, E., & Scott, J. A. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e31822e575b · Cited by 59
Creus, M., Deulofeu, R., Peñarrubia, J., Carmona, F., & Balasch, J. (2013) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2012-0452 · Cited by 37
Metadata
- Authors
- Fatini, C., Gensini, F., Battaglini, B., Prisco, D., Cellai, A. P., Fedi, S., Marcucci, R., Brunelli, T., Mello, G., Parretti, E., Pepe, G., & Abbate, R.
- Venue
- Blood Coagulation and Fibrinolysis
- Published
- 2000-10
- Volume
- 11
- Issue
- 7
- Pages
- 657-662
- ISSN
- 0957-5235 (ISSN-L)
- OpenAlex
- W2043663172
- Cited by
- 74
- References
- 1
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. https://app.cochat.ai/papers/10.1097/00001721-200010000-00010
- The paper
- Fatini, C., Gensini, F., Battaglini, B., Prisco, D., Cellai, A. P., Fedi, S., Marcucci, R., Brunelli, T., Mello, G., Parretti, E., Pepe, G., & Abbate, R. (2000). Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagulation and Fibrinolysis. https://doi.org/10.1097/00001721-200010000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.